Hasselt, capital of Belgian Limburg, combines a strong hospital fabric with industrial giants such as Umicore and Nyrstar and a major biomedical research centre, the UHasselt Biomed. Its large Turkish and Kurdish community, together with the cross-border flows towards the Netherlands, make Dutch-Turkish medical translation and REACH toxicological safety data sheets the two pillars of Hasselt demand. TranslateBE covers the entire medical and industrial spectrum of Limburg.
The Jessa Ziekenhuis and the ZOL: two hospital networks with distinct language needs
The Jessa Ziekenhuis is the main hospital in Hasselt, operating across two complementary sites - Virga Jesse and Salvator - and covering a wide range of medical and surgical specialties. With more than 750 beds and a catchment area extending across the whole of western Limburg, the Jessa serves a diverse population in which the Turkish and Moroccan community is particularly well represented.
The Ziekenhuis Oost-Limburg (ZOL), mainly located in Genk, serves eastern Limburg, a region marked by the historical immigration of Italian, Turkish and Moroccan miners who came to work in the coal mines. The ZOL, a university hospital centre associated with the UHasselt, is also a reference centre for interventional cardiology and oncology. Its medical records, written in Dutch according to Belgian standards, must regularly be translated for patients who return to their country of origin or consult a specialist in the Netherlands.
The Limburg patients treated in the Netherlands constitute a specific cross-border flow: the Maastricht UMC+ is 30 minutes from Hasselt and attracts Belgian patients for certain specialties. The INAMI and its Dutch counterpart, the Zorginstituut Nederland, require precise medical documents for cross-border reimbursement applications. These documents in Belgian Dutch must sometimes be translated into standard Dutch or into other languages depending on the patient's situation.
The Turkish community of Hasselt and Genk: NL to TR, a strategic language pair
Hasselt and Genk are home to one of the largest Turkish communities in Belgium, inherited from the immigration of the 1960s and 1970s in the Limburg coal mines. Many residents of Turkish origin, in particular the first generation, do not have a sufficient command of Dutch to understand a medical record, a hospitalisation report or a complex prescription. The Dutch-Turkish language pair is therefore one of the most requested in Hasselt, a market that few translation agencies cover with genuine medical specialisation.
The Kurdish community, linguistically distinct from the Turkish community, is also present in Hasselt. Kurmanji and Sorani, the two main varieties of Kurdish, are languages in their own right that our translators master. A Kurdish patient treated at the Jessa Ziekenhuis must be able to receive their medical information in a language they genuinely understand, and not in a Turkish that is sometimes foreign to them.
The informed consent forms for the clinical trials conducted at the UHasselt constitute another important segment. When a clinical trial includes Turkish or Moroccan participants, the consent form must be available in Turkish or Arabic. Our medical translators produce these forms in language accessible to a non-expert patient, in line with the requirements of the Medical Ethics Committee of the Hasselt region.
TranslateBE
Certified medical translation in Hasselt
Jessa Ziekenhuis, ZOL, UHasselt Biomed: Dutch-Turkish, SDS Umicore/Nyrstar, biomedical publications. Specialised medical and industrial translators for Limburg.
Umicore and Nyrstar: metal toxicology and industrial safety data sheets
Umicore, headquartered in Brussels but whose precious-metal recycling activities and production of materials for lithium-ion batteries are concentrated in Limburg, is subject to REACH obligations for all of its products. The toxicology of cobalt, nickel, platinum and lithium - core materials in the manufacture of batteries for electric vehicles - is a highly specialised field. The Safety Data Sheets produced by Umicore for these substances must be available in Dutch, French, English, German and in all the languages of the countries where the products are distributed.
These safety data sheets contain toxicological sections of great scientific density: occupational exposure limit values (OELs), data on carcinogenesis (cobalt being classified CMR 1B by the CLP regulation), effects on reproduction, aquatic and terrestrial data for ecotoxicology. Our chemical-toxicological translators have training in life sciences or chemistry and know the nomenclature of the ECHA as well as the classifications of the IARC (International Agency for Research on Cancer).
Nyrstar, producer of zinc and associated metals with installations in Balen in Limburg, generates similar needs for heavy metals such as zinc, lead and cadmium. The medical reports linked to exposure to heavy metals - lead poisoning (saturnism), chronic exposure to cadmium, respiratory effects of zinc - must be translated for occupational physicians, insurers and the labour inspectorate (Welfare at Work Supervision). These reports, produced in Dutch by the Limburg occupational physicians, must sometimes be translated into French or English for compensation procedures.
Biomed UHasselt: world-class biomedical research
The Biomed of the UHasselt (Biomedical Research Institute) is a research centre of international standing specialised in neurodegenerative diseases - multiple sclerosis, Parkinson's, Alzheimer's - and in biocompatible materials for medical applications. Its researchers publish in the best international journals and collaborate with universities worldwide.
These collaborations generate bidirectional translation needs: the research protocols must be translated from English into Dutch for submissions to the Belgian Ethics Committee, while the summaries and information notes for participants in the clinical trials must be available in Turkish, Arabic, French or any other language of the participants. Conversely, publications in Dutch or funding reports in Dutch must sometimes be translated into English for international partners or European funders.
The clinical trials conducted under regulation EU 536/2014 require that informed consent forms be available in the mother tongue of each participant. When the UHasselt recruits Turkish or Moroccan participants for its studies on neurodegenerative diseases, we produce the Turkish, Arabic and other versions of the forms while ensuring the accessibility of the text for a non-expert patient, in line with the recommendations of the Medical Ethics Committee of the province of Limburg.
Indicative timelines and rates for Hasselt
| Type of medical document | Indicative rate | Timeline |
|---|---|---|
| Toxicological REACH SDS cobalt/lithium (Umicore) | 200-500 € per language | 48-72h |
| Patient record NL to TR (Jessa/ZOL) | 130-280 € | 24-48h |
| Heavy-metal exposure report Nyrstar | 150-350 € | 48-72h |
| Biomedical publication UHasselt (EN/NL, per page) | 35-55 €/page | 5-8 days |
| Multilingual clinical trial consent (Turkish, Arabic) | 100-200 € per language | 24-48h |
TranslateBE · Certified Agency
Your medical translation in Hasselt within 24h
Jessa Ziekenhuis, ZOL, UHasselt Biomed, Umicore, Nyrstar: NL-TR medical translations, REACH toxicological SDS, biomedical publications. Free quote within 2h.
FAQ
Frequently asked questions
How do I translate an Umicore toxicological SDS into Turkish and French for the workers?
A toxicological SDS for substances such as cobalt or lithium compounds is a regulatory document structured into 16 sections according to the REACH regulation and the CLP regulation. For the translation into Turkish, we call on translators with training in chemistry or industrial toxicology, able to faithfully render the occupational exposure limit values (OELs), the CMR classifications and the hazard pictograms. For the French version, the terminology must be aligned with the nomenclatures of the INRS (French National Research and Safety Institute) and the official IUPAC names. We deliver both versions simultaneously in the format provided by Umicore (Word or editable PDF) with a revision sheet that facilitates future regulatory updates.
Can a Turkish patient hospitalised at the Jessa Ziekenhuis demand translated documents?
Yes. The Belgian law of 22 August 2002 on patient rights guarantees the right to clear information in a comprehensible language. This implies that the Jessa Ziekenhuis must ensure that a Turkish patient understands the information relating to their diagnosis, the proposed treatments and the risks before any medical procedure. In practice, the hospital may use a community interpreter for oral communication, but the written documents - discharge letter, prescriptions, post-operative instructions - are not systematically translated. The patient may request a translation, but the hospital is not always able to provide it directly. TranslateBE then steps in at the request of the patient or the family to produce these translations within 24 hours, with a specialised Turkish-speaking medical translator.
Does the UHasselt publish its biomedical research in Dutch or in English?
The UHasselt and its research centre Biomed publish almost all of their research work in English, the international scientific language. The articles in the peer-reviewed journals, the doctoral theses and the reports of European projects (Horizon Europe) are written in English. However, the documents intended for the wider Belgian public - press releases, plain language summaries (required by certain funders), annual reports and documents submitted to the Flemish regional authorities - are in Dutch. The information notes for the participants in the clinical trials must be in Dutch (for the Flemish Belgian participants) and in all the other languages of the included participants. We cover all of these translation directions.
Do the medical records of Limburg patients treated in the Netherlands need to be re-translated into Belgian Dutch?
The language boundary between Belgian Dutch and the Dutch of the Netherlands is real but often overestimated in the medical context. The fundamental medical terms are identical in both varieties. However, certain administrative and terminological differences exist: the referral system between general practitioner and specialist is organised differently, the reimbursement nomenclatures of the INAMI and the Zorginstituut Nederland use distinct codes and labels, and certain medicines have different commercial names on either side of the border. When a medical record produced at the Maastricht UMC+ must be submitted to the INAMI for reimbursement, an adaptation by a Belgian translator who knows the Belgian administrative specificities is recommended, even if the base language is Dutch in both cases.